A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
Clinical trial NCT02302807 · COMPLETED
Trial details
- NCT number
- NCT02302807
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-13
- Primary completion
- 2017-03-13
- Enrollment
- 931
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.